Tralokinumab: Unveiling the Promise of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a significant treatment for chronic dermatitis. This humanized antibody targets https://jasperjaxs197611.wikipresses.com/7494628/text